StockWatch
·

TENET HEALTHCARE CORP Q1 FY26 Results

THCQ1 FY26 Results
Filing
MetricValue ($ M)Q1 FY25
Revenue5.4K2.8%
Total Income5.4K2.8%
Expenditure4.1K4.9%
PBT1.1K48.0%
Net Profit702.0072.9%
OPM24.14%6.09pp
NPM13.08%5.30pp
EPS8.0987.7%
View full financials

Tenet Reports Q1 2026 Net Income of $702 Million, Adjusted EPS Up 10.6%

30 Apr 2026 · 30 Apr, 4:22 pm

Summary

Tenet Healthcare Corporation delivered strong first quarter 2026 results, with net operating revenues climbing 2.8% year-over-year to $5,368 million. Net income available to common shareholders saw a substantial increase to $702 million, while adjusted diluted earnings per share rose by 10.6% to $4.82. Consolidated Adjusted EBITDA remained robust at $1.162 billion, yielding a 21.6% margin, and the Ambulatory Care segment's Adjusted EBITDA grew by 6.1% to $484 million. CEO Saum Sutaria emphasized disciplined operations and strong free cash flow, reinforcing the company's commitment to its high acuity strategy and growth initiatives.

Key Highlights

  1. 1

    Net income available to common shareholders for the first quarter of 2026 significantly increased to $702 million, compared to $406 million in the first quarter of 2025.

  2. 2

    Adjusted diluted earnings per share grew by 10.6% to $4.82 in Q1 2026, up from $4.36 in the prior-year period.

  3. 3

    Consolidated Adjusted EBITDA for the first quarter of 2026 was $1.162 billion, achieving an Adjusted EBITDA margin of 21.6%.

  4. 4

    Net operating revenues for Q1 2026 increased by 2.8% year-over-year, reaching $5,368 million.

  5. 5

    The Ambulatory Care segment reported strong growth, with Adjusted EBITDA increasing by 6.1% to $484 million in the first quarter of 2026.

  6. 6

    Net cash flows provided by operating activities more than doubled to $1.641 billion for the three months ended March 31, 2026, compared to $815 million in the same period last year.

  7. 7

    The company repurchased 1.35 million shares of common stock for $318 million during the first quarter of 2026.

Management Comments

S

Saum Sutaria

M.D.

We delivered strong results in both the Ambulatory and Hospital segments in the first quarter of 2026, characterized by disciplined operations and strong free cash flow. We continue to support our physician partners to drive innovation in patient care as we execute on our high acuity strategy and grow our businesses both organically and inorganically.

Informational and educational content only. Not investment advice.